Hydroquinone

Hydroquinone

SCHEMBL700283

CCCCOCCCC.Oc1ccc(O)cc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.63
NR5A1 Q13285 1/20 0.63
ESR1 P03372 7/20 0.57
TSHR P16473 3/20 0.57
LMNA P02545 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
MAPK1 P28482 1/20 0.57
CYP2C19 P33261 1/20 0.57
NR1H2 P55055 1/20 0.57
RNASEL Q05823 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
SLC6A2 P23975 3/20 0.50
ALDH1A1 P00352 3/20 0.50
ADRA2A P08913 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
TACR2 P21452 2/20 0.50
SLC6A4 P31645 2/20 0.50
SLC6A3 Q01959 2/20 0.50
CHRM1 P11229 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroquinone SCHEMBL2945920 0.93 NR5A1 (0.67) LTA4HNR5A1ESR1TSHRLMNA
P-Cresol SCHEMBL28969724 0.91 LTA4H (0.55) LTA4HNR5A1ESR1TSHRLMNA
Hydroquinone SCHEMBL3891638 0.91 NR5A1 (0.70) LTA4HNR5A1ESR1TSHRLMNA
Hydroquinone SCHEMBL2946399 0.91 NR5A1 (0.70) LTA4HNR5A1ESR1TSHRLMNA
Hydroquinone SCHEMBL2945404 0.91 NR5A1 (0.70) LTA4HNR5A1ESR1TSHRLMNA
Hydroquinone SCHEMBL10845593 0.91 NR5A1 (0.70) LTA4HNR5A1ESR1TSHRLMNA
Hydroquinone SCHEMBL4635427 0.91 NR5A1 (0.70) LTA4HNR5A1ESR1TSHRLMNA
Hydroquinone SCHEMBL4636167 0.91 NR5A1 (0.70) LTA4HNR5A1ESR1TSHRLMNA
Hydroquinone SCHEMBL2944714 0.91 NR5A1 (0.70) LTA4HNR5A1ESR1TSHRLMNA
SCHEMBL10743243 0.89 LTA4H (0.75) LTA4HNR5A1ESR1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085028-A1 P-XYLENE CYCLIC DIMER DERIVATIVE FOR PREPARING PARYLENE FILM, AND PREPARATION METHOD AND USE THEREOF UNIV SOOCHOW (CN) 2026-03-26 US claimed
CN-116396150-A Production process of formaldehyde 上海春宝化工有限公司 2023-07-07 CN claimed
WO-2021082035-A1 LIQUID CRYSTAL DISPLAY PANEL AND MANUFACTURING METHOD THEREFOR 武汉华星光电技术有限公司 2021-05-06 WO claimed
CN-105061808-B A kind of preparation method of rubber antioxidant 江苏麒祥高新材料有限公司 2018-02-23 CN claimed
EP-1656551-A1 LEAK DETECTION METHOD USING MICROENCAPSULATED DYE PRECURSOR Honeywell International Inc. (US) 2006-05-17 EP claimed
WO-2005019816-A1 LEAK DETECTION METHOD USING MICROENCAPSULATED DYE PRECURSOR HONEYWELL INTERNATIONAL, INC. (US) 2005-03-03 WO claimed
US-20050042758-A1 Leak detection method using microencapsulated dye precursor HONEYWELL CORPORATION 2005-02-24 US claimed
US-20260085028-A1 P-XYLENE CYCLIC DIMER DERIVATIVE FOR PREPARING PARYLENE FILM, AND PREPARATION METHOD AND USE THEREOF UNIV SOOCHOW (CN) 2026-03-26 US disclosed
US-20250333555-A1 COMPOSITION AND METHOD FOR PRODUCING ARTICLE CANON KK (JP) 2025-10-30 US disclosed
US-12403647-B2 Photo fabrication resin composition, model material composition, and photo-cured product thereof, and photo fabrication composition set MAXELL, LTD. (JP) 2025-09-02 US disclosed
US-20250257221-A1 PHOTOCURABLE RESIN COMPOSITION CANON KABUSHIKI KAISHA (JP) 2025-08-14 US disclosed
US-12291648-B2 Energy ray-curable resin compositions and its cured products CANON KABUSHIKI KAISHA (JP) 2025-05-06 US disclosed
EP-3476874-B1 RESIN COMPOSITION FOR MODEL MEMBER AND METHOD FOR MANUFACTURING OPTICALLY SHAPED ARTICLE MAXELL LTD (JP) 2025-03-12 EP disclosed
US-4631252-A PHOTOGRAPHIC STABILIZERS CIBA-GEIGY AG (CH) 1986-12-23 US disclosed
US-4616082-A PHOTOGRAPHIC STABILIZERS CIBA-GEIGY AG (CH) 1986-10-07 US disclosed
US-4549015-A PHOTOHRAPHIC STABILIZERS CIBA-GEIGY AG (CH) 1985-10-22 US disclosed
US-4214104-A Use of cyclohexene-(1)-dione-(3,6)-tetraalkyl diketals HOECHST AKTIENGESELLSCHAFT (DE) 1980-07-22 US disclosed
US-4160109-A CYCLOHEXENE-(1)-DIONE-(3,6)-TETRAALKYLDIKETALS AND PROCESS HOECHST AKTIENGESELLSCHAFT (DE) 1979-07-03 US disclosed
US-4102859-A PHOSPHOROUS ACID ESTERS WITH OXETANE COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 1978-07-25 US disclosed
US-4034039-A Purification of methylenedianilines THE UPJOHN COMPANY (US) 1977-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085028-A1 P-XYLENE CYCLIC DIMER DERIVATIVE FOR PREPARING PARYLENE FILM, AND PREPARATION METHOD AND USE THEREOF F12, F2, PF4 LTA4H 418/4885NR5A1 2625/4885ESR1 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.